Therapeutische Anwendung des Progesteronantagonisten "Onapriston" im transgenen 
Rattenmodell der Charcot-Marie-Tooth-Erkrankung Typ 1A (CMT1A)

Meyer zu Hörste, Gerd

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Thesis

Therapeutische Anwendung des Progesteronantagonisten "Onapriston" im transgenen Rattenmodell der Charcot-Marie-Tooth-Erkrankung Typ 1A (CMT1A)

MPS-Authors

/persons/resource/persons182297

Meyer zu Hörste, Gerd
Molecular and translational neurology, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Diss Meyer zu Hörste.pdf
(Any fulltext), 3MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Meyer zu Hörste, G. (2006). Therapeutische Anwendung des Progesteronantagonisten "Onapriston" im transgenen Rattenmodell der Charcot-Marie-Tooth-Erkrankung Typ 1A (CMT1A). PhD Thesis, Georg-August-Universität, Göttingen.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002A-1FBB-2

Abstract

There is no abstract available